Mass spectrometry is a powerful tool in plasma medicine, analyzing molecular changes in treated samples. It ionizes molecules, measures their mass-to-charge ratio , and provides crucial information about structure, composition, and abundance of plasma-altered biological molecules.
Various ionization techniques, mass analyzers, and detectors enable precise analysis of plasma-treated samples. This method helps researchers understand plasma-induced modifications , identify biomarkers, study drug metabolism, and characterize protein changes, advancing our knowledge of plasma-cell interactions and therapeutic effects.
Principles of mass spectrometry
Analyzes molecules by ionizing them and measuring their mass-to-charge ratio
Provides crucial information about molecular structure, composition, and abundance in plasma medicine research
Enables identification and quantification of complex biological molecules altered by plasma treatment
Ionization techniques
Top images from around the web for Ionization techniques Frontiers | Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area View original
Is this image relevant?
Frontiers | MALDI-TOF mass spectrometry: an emerging technology for microbial identification and ... View original
Is this image relevant?
Frontiers | Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area View original
Is this image relevant?
Frontiers | MALDI-TOF mass spectrometry: an emerging technology for microbial identification and ... View original
Is this image relevant?
1 of 2
Top images from around the web for Ionization techniques Frontiers | Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area View original
Is this image relevant?
Frontiers | MALDI-TOF mass spectrometry: an emerging technology for microbial identification and ... View original
Is this image relevant?
Frontiers | Detection of Antibiotic-Resistance by MALDI-TOF Mass Spectrometry: An Expanding Area View original
Is this image relevant?
Frontiers | MALDI-TOF mass spectrometry: an emerging technology for microbial identification and ... View original
Is this image relevant?
1 of 2
Electron ionization (EI) bombards molecules with high-energy electrons to create positive ions
Electrospray ionization (ESI) nebulizes liquid samples into charged droplets
Matrix-assisted laser desorption/ionization (MALDI) uses laser energy absorbed by a matrix to ionize molecules
Atmospheric pressure chemical ionization (APCI) ionizes vaporized samples through gas-phase ion-molecule reactions
Mass analyzers
Quadrupole mass analyzer uses oscillating electric fields to separate ions based on their m/z ratio
Time-of-flight (TOF) analyzer measures the time taken for ions to travel a fixed distance
Ion trap analyzer captures ions in a three-dimensional electric field
Fourier transform ion cyclotron resonance (FT-ICR) analyzer provides ultra-high mass resolution
Orbitrap analyzer traps ions in an electrostatic field and measures their oscillation frequency
Detectors in mass spectrometry
Electron multiplier amplifies the ion signal by generating secondary electrons
Faraday cup collects ions directly and measures the resulting current
Microchannel plate detector consists of multiple electron multipliers for improved sensitivity
Array detector simultaneously detects multiple m/z values for increased speed and sensitivity
Plasma treatment of samples
Modifies surface properties and chemical composition of biological samples
Generates reactive species that interact with sample molecules, creating new compounds
Enhances ionization efficiency and improves mass spectrometry analysis in plasma medicine
Types of plasma sources
Dielectric barrier discharge (DBD) plasma generates non-equilibrium plasma at atmospheric pressure
Atmospheric pressure plasma jet (APPJ) produces a stream of reactive species for localized treatment
Microwave-induced plasma creates high-density plasma for efficient sample treatment
Inductively coupled plasma (ICP) generates high-temperature plasma for elemental analysis
Plasma-sample interactions
Reactive oxygen species (ROS) oxidize organic molecules in the sample
Reactive nitrogen species (RNS) induce nitration and nitrosylation of biomolecules
UV radiation from plasma causes photochemical reactions and bond cleavage
Charged particles in plasma modify surface charge distribution of samples
Chemical modifications by plasma
Oxidation of lipids and proteins leads to formation of carbonyl and hydroxyl groups
Nitration of aromatic amino acids (tyrosine) alters protein structure and function
Crosslinking of polymers increases molecular weight and changes physical properties
Fragmentation of large molecules produces smaller, more easily ionized species
Sample preparation methods
Crucial step in mass spectrometry analysis of plasma-treated samples
Affects ionization efficiency, spectral quality, and overall analytical performance
Tailored to specific sample types and target analytes in plasma medicine research
Solid vs liquid samples
Solid samples require dissolution, extraction, or direct ionization techniques (MALDI)
Liquid samples can be directly analyzed using electrospray ionization or undergo further preparation
Biological tissues often require homogenization and extraction before analysis
Cell cultures may need lysis and protein precipitation steps
Liquid-liquid extraction separates analytes based on their solubility in immiscible solvents
Solid-phase extraction (SPE) uses adsorbent materials to selectively retain and elute analytes
Supercritical fluid extraction employs supercritical CO2 for efficient extraction of non-polar compounds
Microwave-assisted extraction accelerates extraction process using microwave energy
Sample concentration
Evaporation under nitrogen stream concentrates samples by removing volatile solvents
Lyophilization (freeze-drying) removes water from samples while preserving heat-sensitive compounds
Solid-phase microextraction (SPME) concentrates analytes on a fiber coating
Molecular imprinted polymers (MIPs) selectively extract and concentrate specific target molecules
Mass spectrometry analysis
Provides detailed molecular information about plasma-treated samples
Enables identification and quantification of chemical changes induced by plasma treatment
Crucial for understanding the effects of plasma on biological systems in plasma medicine
Qualitative vs quantitative analysis
Qualitative analysis identifies compounds based on their mass spectra and fragmentation patterns
Quantitative analysis determines the concentration of specific analytes using calibration curves
Relative quantification compares abundance of analytes between different samples or conditions
Absolute quantification requires internal standards with known concentrations
Spectral interpretation
Mass spectrum displays ion intensity vs mass-to-charge ratio (m/z)
Molecular ion peak (M+) represents the intact molecule and provides molecular weight information
Fragment ions result from molecule fragmentation and provide structural information
Isotope patterns help confirm elemental composition and identify halogenated compounds
Data processing techniques
Peak detection algorithms identify and measure ion signals in mass spectra
Deconvolution separates overlapping peaks and resolves complex spectra
Background subtraction removes chemical noise and improves signal-to-noise ratio
Normalization adjusts for variations in sample amount or instrument response
Applications in plasma medicine
Mass spectrometry analyzes molecular changes induced by plasma treatment in biological systems
Provides insights into mechanisms of plasma-cell interactions and therapeutic effects
Supports development of targeted plasma treatments for various medical applications
Biomarker identification
Discovers molecular signatures associated with plasma-induced cellular responses
Identifies oxidative stress markers (8-OHdG) in plasma-treated tissues
Detects changes in lipid profiles following plasma exposure
Analyzes post-translational modifications of proteins induced by plasma treatment
Investigates plasma-induced changes in drug metabolism and pharmacokinetics
Identifies new metabolites formed through plasma-mediated drug modifications
Quantifies changes in drug concentrations following plasma treatment
Analyzes plasma-induced alterations in drug-protein binding
Protein modifications
Characterizes oxidative modifications of proteins (carbonylation) caused by plasma treatment
Identifies nitration and nitrosylation of amino acid residues in proteins
Analyzes plasma-induced protein crosslinking and aggregation
Detects changes in protein phosphorylation patterns following plasma exposure
Challenges and limitations
Mass spectrometry analysis of plasma-treated samples faces several technical and analytical challenges
Addressing these limitations improves accuracy and reliability of results in plasma medicine research
Ongoing developments in instrumentation and methodology aim to overcome these obstacles
Matrix effects
Co-eluting matrix components suppress or enhance ionization of target analytes
Biological matrices (plasma, tissue extracts) introduce complex interferences
Internal standards and matrix-matched calibration help compensate for matrix effects
Advanced sample preparation techniques (immunoaffinity extraction) reduce matrix interference
Ion suppression
Occurs when matrix components compete with analytes for ionization
Reduces sensitivity and affects quantitative accuracy of mass spectrometry analysis
Dilution of samples or use of alternative ionization techniques can mitigate ion suppression
Chromatographic separation before mass spectrometry analysis reduces co-elution of interfering compounds
Sample degradation
Plasma-induced modifications can continue during sample storage and preparation
Oxidation and hydrolysis of unstable compounds lead to loss of analytes
Antioxidants and stabilizers added to samples prevent further degradation
Rapid sample processing and analysis minimize degradation-related artifacts
Advanced techniques
Cutting-edge mass spectrometry methods enhance analysis of plasma-treated samples
Provide higher sensitivity, selectivity, and structural information
Enable comprehensive characterization of complex biological systems in plasma medicine
Tandem mass spectrometry
MS/MS involves multiple stages of mass analysis for improved structural elucidation
Collision-induced dissociation (CID) fragments precursor ions for detailed structural information
Precursor ion scanning identifies compounds with specific structural features
Neutral loss scanning detects molecules that lose a specific neutral fragment
Imaging mass spectrometry
Maps spatial distribution of molecules in tissue sections or cell cultures
MALDI imaging analyzes molecular changes across plasma-treated tissue surfaces
Secondary ion mass spectrometry (SIMS) provides high spatial resolution for surface analysis
Desorption electrospray ionization (DESI) enables ambient imaging of biological samples
High-resolution mass spectrometry
Orbitrap and FT-ICR analyzers provide ultra-high mass resolution and accuracy
Enables accurate mass measurements for elemental composition determination
Resolves complex mixtures and identifies closely related compounds
Improves confidence in compound identification and reduces false positives
Data analysis and interpretation
Processes and extracts meaningful information from mass spectrometry data of plasma-treated samples
Integrates multiple data sources to gain comprehensive insights into plasma-induced changes
Crucial for translating mass spectrometry results into clinically relevant findings in plasma medicine
Statistical methods
Principal component analysis (PCA) identifies patterns and groupings in complex datasets
Partial least squares discriminant analysis (PLS-DA) classifies samples based on spectral features
ANOVA and t-tests determine statistical significance of observed changes
Multiple testing correction (Bonferroni, FDR) controls for false positives in large-scale analyses
Pathway analysis software (KEGG, Reactome) maps identified molecules to biological pathways
Protein interaction databases (STRING) reveal functional relationships between modified proteins
Gene ontology (GO) enrichment analysis identifies overrepresented biological processes
Machine learning algorithms predict functional consequences of plasma-induced modifications
Database searching
Spectral libraries (NIST, MassBank) aid in compound identification by spectral matching
Protein databases (UniProt, NCBI) support identification of modified peptides and proteins
Metabolite databases (HMDB, METLIN) facilitate annotation of small molecules
In-house databases of plasma-specific modifications improve identification accuracy
Emerging trends
Cutting-edge developments in mass spectrometry push boundaries of plasma medicine research
Enhance speed, sensitivity, and applicability of mass spectrometry in clinical settings
Enable new insights into plasma-biological interactions and therapeutic mechanisms
Real-time analysis
Rapid evaporative ionization mass spectrometry (REIMS) enables real-time tissue analysis during plasma treatment
Ambient ionization techniques (DART, DESI) allow direct analysis of samples without preparation
Ion mobility spectrometry-mass spectrometry (IMS-MS) provides rapid separation and analysis of complex mixtures
Online monitoring of plasma-induced changes using microfluidic devices coupled to mass spectrometers
Miniaturization of instruments
Portable mass spectrometers enable on-site analysis of plasma-treated samples
Microfluidic paper-based analytical devices (μPADs) coupled to miniature mass spectrometers
Handheld mass spectrometers for point-of-care diagnostics in plasma medicine applications
Lab-on-a-chip devices integrate sample preparation and mass spectrometry analysis
Coupling with other techniques
Hyphenated techniques combine mass spectrometry with complementary analytical methods
LC-MS/MS improves separation and identification of complex plasma-treated samples
Ion mobility-mass spectrometry (IM-MS) enhances separation of isomers and conformers
Mass cytometry (CyTOF) enables high-dimensional analysis of cellular responses to plasma treatment